Ross Nathan T, Lohmann Felix, Carbonneau Seth, Fazal Aleem, Weihofen Wilhelm A, Gleim Scott, Salcius Michael, Sigoillot Frederic, Henault Martin, Carl Sarah H, Rodríguez-Molina Juan B, Miller Howard R, Brittain Scott M, Murphy Jason, Zambrowski Mark, Boynton Geoffrey, Wang Yuan, Chen Aye, Molind Gregory J, Wilbertz Johannes H, Artus-Revel Caroline G, Jia Min, Akinjiyan Favour A, Turner Jonathan, Knehr Judith, Carbone Walter, Schuierer Sven, Reece-Hoyes John S, Xie Kevin, Saran Chitra, Williams Eric T, Roma Guglielmo, Spencer Matt, Jenkins Jeremy, George Elizabeth L, Thomas Jason R, Michaud Gregory, Schirle Markus, Tallarico John, Passmore Lori A, Chao Jeffrey A, Beckwith Rohan E J
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Vertex Pharmaceuticals, Boston, MA, USA.
Nat Chem Biol. 2020 Apr;16(4):479. doi: 10.1038/s41589-020-0508-y.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
本文的一个修订版本已发表,可通过本文顶部的链接获取。